SCPXNightHawk Biosciences, Inc.

NYSE nighthawkbio.com


$ 0.90 $ 0.06 (6.62 %)    

Tuesday, 20-Aug-2024 15:08:01 EDT
QQQ $ 480.91 $ -0.39 (-0.08 %)
DIA $ 408.42 $ -0.47 (-0.11 %)
SPY $ 559.00 $ -0.16 (-0.03 %)
TLT $ 98.59 $ 0.29 (0.3 %)
GLD $ 232.27 $ -1.45 (-0.62 %)
$ 0.95
$ 0.85
$ 0.92 x 1,488
$ 0.91 x 100
$ 0.83 - $ 1.02
$ 0.07 - $ 7.22
815,727
na
312,530
$ -1.45
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-19-2024 06-30-2024 10-Q
2 05-28-2024 03-31-2024 10-Q
3 04-26-2024 12-31-2023 10-K
4 11-20-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-31-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-10-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-11-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-11-2021 06-30-2021 10-Q
14 05-05-2021 03-31-2021 10-Q
15 03-25-2021 12-31-2020 10-K
16 11-09-2020 09-30-2020 10-Q
17 08-07-2020 06-30-2020 10-Q
18 05-15-2020 03-31-2020 10-Q
19 03-30-2020 12-31-2019 10-K
20 11-14-2019 09-30-2019 10-Q
21 08-14-2019 06-30-2019 10-Q
22 05-15-2019 03-31-2019 10-Q
23 03-28-2019 12-31-2018 10-K
24 11-14-2018 09-30-2018 10-Q
25 08-14-2018 06-30-2018 10-Q
26 05-15-2018 03-31-2018 10-Q
27 03-02-2018 12-31-2017 10-K
28 11-13-2017 09-30-2017 10-Q
29 08-14-2017 06-30-2017 10-Q
30 05-11-2017 03-31-2017 10-Q
31 03-31-2017 12-31-2016 10-K
32 11-10-2016 09-30-2016 10-Q
33 08-15-2016 06-30-2016 10-Q
34 05-11-2016 03-31-2016 10-Q
35 02-18-2016 12-31-2015 10-K
36 10-30-2015 09-30-2015 10-Q
37 08-13-2015 06-30-2015 10-Q
38 05-14-2015 03-31-2015 10-Q
39 03-27-2015 12-31-2014 10-K
40 11-14-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Scorpius Holdings (AMEX: SCPX) reported quarterly losses of $(26.98) per share. The company reported $759.94 thousand in sales ...

Core News & Articles

With 45-Day Option for Additional 1.875M Shares; Receives NYSE American Financial Viability Exception Approval

Core News & Articles

Scorpius Holdings, Inc. (NYSE:SCPX) ("Scorpius" or "the Company"), an integrated contract development and manuf...

Core News & Articles

However, there can be no assurance that that the Reverse Stock Split will increase the Company's stock price sufficiently i...

Core News & Articles

-Reuters

Core News & Articles

Collaboration aims to enhance biomanufacturing reliability, scalability and efficiency Autonomous humanoids designed to complem...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION